bridging science with industry
Inorgen: a European advisory translating research into therapies
Inorgen is an advisory who taps the research potential of academia and research institutions, providing them a way to translate breakthrough discoveries from research into therapies for patients.
Inorgen operates with an entrepreneurial approach in the biopharma industry, with the following activities:
- Venture Capital / Board & Advisory / Business Development
- Management / Advisory to biopharma
- Venture Building / Entrepreneur In Residence / Translation of research into therapies and for successful exits